• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

库欣综合征患者的生活质量。

Quality of life in Cushing's syndrome.

机构信息

Faculty of Health and Medicine, University of Lancaster, UK.

Department of Basic Sciences, School of Medicine and Health Sciences, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.

出版信息

Best Pract Res Clin Endocrinol Metab. 2021 Jan;35(1):101505. doi: 10.1016/j.beem.2021.101505. Epub 2021 Feb 17.

DOI:10.1016/j.beem.2021.101505
PMID:33707083
Abstract

Measurement of Health-Related Quality of Life (HRQoL) is emerging as an important clinical endpoint which complements diagnostic workup and contributes to place patients at the centre of the decision-making process through the recognition of their needs, concerns, goals and expectations. Chronic excessive cortisol exposure in Cushing's syndrome (CS) causes severe physical and psychological morbidity which invariably affects HRQoL during the active phase of the disease and even after successful treatment. This sustained deterioration of patient's wellbeing is partly related to the persistence of several features associated with prior cortisol excess, including affective disorders, cognitive dysfunctions and negative illness perception. The aim of this review is to summarize the most recent evidence on HRQoL in CS, including the main determinants of its impairment and the results of some educational programs specifically addressed to improve patient's coping abilities. The preliminary results of an unpublished survey on patient's unmet needs will also be presented.

摘要

健康相关生活质量(HRQoL)的测量正在成为一个重要的临床终点,它补充了诊断工作,并通过认识患者的需求、关注点、目标和期望,将患者置于决策过程的中心。库欣综合征(CS)中慢性过量皮质醇暴露会导致严重的身体和心理发病率,这不可避免地会在疾病的活动期甚至在成功治疗后影响 HRQoL。患者健康状况的持续恶化部分与与先前皮质醇过多相关的几个特征的持续存在有关,包括情感障碍、认知功能障碍和对疾病的负面认知。本综述的目的是总结 CS 中 HRQoL 的最新证据,包括其受损的主要决定因素,以及一些专门旨在提高患者应对能力的教育计划的结果。还将介绍一项关于患者未满足需求的未发表调查的初步结果。

相似文献

1
Quality of life in Cushing's syndrome.库欣综合征患者的生活质量。
Best Pract Res Clin Endocrinol Metab. 2021 Jan;35(1):101505. doi: 10.1016/j.beem.2021.101505. Epub 2021 Feb 17.
2
Morbidity of Cushing's Syndrome and Impact of Treatment.库欣综合征的发病率及治疗影响。
Endocrinol Metab Clin North Am. 2018 Jun;47(2):299-311. doi: 10.1016/j.ecl.2018.01.001. Epub 2018 Apr 9.
3
Cushing's syndrome: Overview of clinical presentation, diagnostic tools and complications.库欣综合征:临床表现、诊断工具和并发症概述。
Best Pract Res Clin Endocrinol Metab. 2020 Mar;34(2):101380. doi: 10.1016/j.beem.2020.101380. Epub 2020 Jan 30.
4
Cushing's syndrome: update on signs, symptoms and biochemical screening.库欣综合征:体征、症状及生化筛查的最新进展
Eur J Endocrinol. 2015 Oct;173(4):M33-8. doi: 10.1530/EJE-15-0464. Epub 2015 Jul 8.
5
Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases.异位促肾上腺皮质激素(ACTH)分泌所致库欣综合征伴高血压和低钾血症:58例病例系列研究
Ann N Y Acad Sci. 2002 Sep;970:134-44. doi: 10.1111/j.1749-6632.2002.tb04419.x.
6
[Cyclic Cushing's Syndrome - rare or rarely recognized].[周期性库欣综合征——罕见或鲜被认识到]
Przegl Lek. 2015;72(2):74-7.
7
Personality characteristics and quality of life in patients treated for Cushing's syndrome.库欣综合征患者的人格特征与生活质量
Clin Endocrinol (Oxf). 2006 Mar;64(3):314-8. doi: 10.1111/j.1365-2265.2006.02462.x.
8
Psychiatric disorders associated with Cushing's syndrome.与库欣综合征相关的精神障碍
Psychiatr Danub. 2015 Sep;27 Suppl 1:S339-43.
9
Psychological complications of Cushing's syndrome.库欣综合征的心理并发症。
Curr Opin Endocrinol Diabetes Obes. 2021 Jun 1;28(3):325-329. doi: 10.1097/MED.0000000000000633.
10
Epidemiology and mortality of Cushing's syndrome.库欣综合征的流行病学和死亡率。
Best Pract Res Clin Endocrinol Metab. 2021 Jan;35(1):101521. doi: 10.1016/j.beem.2021.101521. Epub 2021 Mar 15.

引用本文的文献

1
Circulating Neuronal Exosome Cargo as Biomarkers of Neuroplasticity in Cushing's Syndrome.循环神经元外泌体货物作为库欣综合征神经可塑性的生物标志物
Mol Neurobiol. 2025 May 24. doi: 10.1007/s12035-025-05069-z.
2
Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease.奥昔布宁治疗库欣病的 III 期 LINC3 试验结果:临床高皮质醇血症特征改善。
J Endocrinol Invest. 2024 Oct;47(10):2437-2448. doi: 10.1007/s40618-024-02359-6. Epub 2024 May 2.
3
Gut microbial dysbiosis in patients with Cushing's disease in long-term remission. Relationship with cardiometabolic risk.
库欣病患者长期缓解后的肠道微生物失调。与心脏代谢风险的关系。
Front Endocrinol (Lausanne). 2023 Jun 5;14:1074757. doi: 10.3389/fendo.2023.1074757. eCollection 2023.
4
Determinants of muscle function and health-related quality of life in patients with endogenous hypercortisolism: a cross-sectional study.内源性皮质醇增多症患者肌肉功能和健康相关生活质量的决定因素:一项横断面研究。
Eur J Endocrinol. 2023 Jul 10;188(7):603-612. doi: 10.1093/ejendo/lvad069.
5
Misdiagnosed psychiatric manifestations in a rare disease: a case report of secondary anxiety syndrome in Cushing's disease.一种罕见疾病中的误诊精神症状:库欣病继发焦虑综合征的病例报告
Front Psychiatry. 2023 Apr 27;14:1190899. doi: 10.3389/fpsyt.2023.1190899. eCollection 2023.
6
Functional brain alterations in Cushing's syndrome.库欣综合征的功能性大脑改变。
Front Endocrinol (Lausanne). 2023 Apr 21;14:1163482. doi: 10.3389/fendo.2023.1163482. eCollection 2023.
7
Role of Prednisolone in Platelet Activation by Inhibiting TxA Generation through the Regulation of cPLA Phosphorylation.泼尼松龙通过调节cPLA磷酸化抑制血栓素A生成在血小板活化中的作用
Animals (Basel). 2023 Apr 11;13(8):1299. doi: 10.3390/ani13081299.
8
The Entity of Connshing Syndrome: Primary Aldosteronism with Autonomous Cortisol Secretion.康欣综合征的实体:原发性醛固酮增多症伴自主性皮质醇分泌。
Diagnostics (Basel). 2022 Nov 13;12(11):2772. doi: 10.3390/diagnostics12112772.
9
Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes.左卡尼汀治疗内源性库欣综合征:临床、生化和影像学结果的扩展评估。
Eur J Endocrinol. 2022 Nov 24;187(6):859-871. doi: 10.1530/EJE-22-0506. Print 2022 Dec 1.
10
Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension.库欣病患者服用奥昔布宁长期疗效:LINC 3 研究扩展。
Eur J Endocrinol. 2022 Sep 16;187(4):531-541. doi: 10.1530/EJE-22-0317. Print 2022 Oct 1.